文献速递衰弱、肌少症与跌倒多重用药认知障碍与谵妄

衰弱程度对抗精神病药物与骨折风险关联的重要性:基于电子健康记录的队列研究

Importance of Frailty for Association of Antipsychotic Drug Use With Risk of Fracture: Cohort Study Using Electronic Health Records.
PubMed 文献 · J Am Med Dir Assoc · 2019-07-01

基于英国临床实践研究数据链153,304例80岁及以上患者(平均83岁,61.3%女性,21,365例骨折),分析第一代和第二代抗精神病药物暴露与骨折风险在不同衰弱水平下的关联。调整衰弱及协变量后,第一代AP与任何骨折风险相关(RR 1.24),第二代AP与股骨骨折相关(RR 1.41)。衰弱患者接受AP治疗的可能性更高,且AP相关骨折的绝对风险显著高于非衰弱患者。

要点

  • 第一代抗精神病药暴露与任何骨折风险相关,调整后RR 1.24(95%CI 1.07-1.43)。
  • 第二代抗精神病药与股骨骨折相关(RR 1.41),与任何骨折关联较弱(RR 1.12)。
  • 严重衰弱者第一代AP治疗每75人年关联1例额外骨折,而体能尚可者为187人年。

核心结论

  • 衰弱患者更可能接受抗精神病药物治疗,但其AP相关骨折的绝对风险显著高于非衰弱患者。

研究设计与样本

  • 基于英国临床实践研究数据链(Clinical Practice Research Datalink)的人群队列研究,纳入2006至2015年间153,304例80岁及以上患者,共分析165,726个治疗 episode。

主要发现

  • 共记录21,365例骨折,随访681,221.1人年;AP暴露与年龄增长、衰弱及痴呆诊断相关。
  • 调整衰弱及协变量后,第一代AP暴露与任何骨折风险相关,RR 1.24(95%CI 1.07-1.43,P=.003)。
  • 第二代AP暴露与股骨骨折相关,RR 1.41(95%CI 1.22-1.64,P<.001);与任何骨折关联较弱,RR 1.12(95%CI 1.01-1.24,P=.033)。
  • 骨折发生率随衰弱水平升高而增加。
  • 严重衰弱患者第一代AP治疗每75人年(42-257)关联1例额外任何部位骨折,而体能尚可(fit)患者为187人年(95%CI 104-640);第二代AP每173人年(111-323)关联1例额外股骨骨折(严重衰弱),体能尚可者为365人年(234-681)。

临床怎么用

  • 对80岁及以上衰弱患者处方抗精神病药物时,应充分评估骨折风险,尤其是第一代AP与任何骨折、第二代AP与股骨骨折的关联。
  • 衰弱程度越重,AP相关骨折的绝对风险越高,临床决策中应将衰弱评估纳入风险获益权衡。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To evaluate association of first- or second-generation antipsychotic (AP) drugs with fracture risk at different levels of frailty over the age of 80 years. DESIGN: Population-based cohort study. SETTING AND PARTICIPANTS: United Kingdom Clinical Practice Research Datalink including 153,304 patients aged 80 years and older between 2006 and 2015. METHODS: Rates of fracture and adjusted rate ratios (RR) were estimated by AP drug exposure category, adjusting for age, sex, frailty, number of deficits, and dementia diagnosis. RESULTS: Data were analyzed for 165,726 treatment episodes (153,304 patients; 61.3% women; mean age 83 years; 21,365 fractures; 681,221.1 person-years of follow-up). AP exposure was associated with increasing age, frailty, and dementia diagnosis. After adjusting for frailty and covariates, first-generation AP exposure was associated with risk of any fracture, RR 1.24 (95% confidence interval 1.07-1.43, P = .003). Second-generation AP exposure was associated with femur fracture (RR 1.41, 1.22-1.64, P < .001) but less strongly with any fracture (RR 1.12, 1.01-1.24, P = .033). Fracture incidence increased with frailty level. The number of person-years of first-generation AP treatment associated with 1 additional fracture at any site was 75 (42-257) for severely frail patients but 187 (95% confidence interval 104-640) for 'fit' patients. For second-generation AP, 1 additional femur fracture might result from 173 (111-323) person-years treatment in severe frailty but 365 (234-681) person-years treatment for 'fit' patients. CONCLUSIONS AND IMPLICATIONS: Frail patients are more likely to receive AP drug treatment, but their absolute risk of AP-associated fracture is substantially greater than for nonfrail patients.

来源:J Am Med Dir Assoc,查看原文。版权归原作者所有。

引用

  1. Gafoor R, Charlton J, Ravindrarajah R, et al. Importance of Frailty for Association of Antipsychotic Drug Use With Risk of Fracture: Cohort Study Using Electronic Health Records. J Am Med Dir Assoc. 2019. PMID: 31272856. doi:10.1016/j.jamda.2019.05.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。